Page last updated: 2024-08-25

magnolol and Cholangiocellular Carcinoma

magnolol has been researched along with Cholangiocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ren, HY; Shen, DY; Shen, JX; Ye, HM; Zhang, FH; Zhang, XY	1

Other Studies

1 other study(ies) available for magnolol and Cholangiocellular Carcinoma

Article	Year
Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 94 Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Humans; Lignans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Signal Transduction; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays	2017

Article

Year

Magnolol suppresses the proliferation and invasion of cholangiocarcinoma cells via inhibiting the NF-κB signaling pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 94

Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Humans; Lignans; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; NF-kappa B; Signal Transduction; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2017